-
J&J developing many next-gen vaccines against COVID-19: CEO
expresspharma
March 19, 2021
Johnson & Johnson is developing several next-generation COVID-19 vaccines against the emerging variants of the coronavirus, said Alex Gorsky, CEO of the company.
-
Potential COVID-19 vaccine not ‘single solution’ to pandemic, Johnson & Johnson CEO says
expresspharma
July 10, 2020
Gorsky said it was a good thing other companies are experimenting with different approaches to vaccines, in part because different vaccines might work better in different groups of people.
-
Talc lawyer says J&J's multibillion-dollar stock woes make settling look like a better deal
fiercepharma
December 25, 2018
What's bad for Johnson & Johnson shares is good for the trial lawyer leading the charge in the talc liability litigation—or so the lawyer says, as J&J scrambles to contain the damage from a bombshell Reuters report Friday.
-
Talc lawyer says J&J's multibillion-dollar stock woes make settling look like a better deal
pharmatimes
December 20, 2018
What's bad for Johnson & Johnson shares is good for the trial lawyer leading the charge in the talc liability litigation—or so the lawyer says, as J&J scrambles to contain the damage from a bombshell Reuters report Friday.
-
Johnson & Johnson CEO Alex Gorsky dines with Trump as president promises ‘substantial’ drug price cuts
fiercepharma
August 09, 2018
Johnson & Johnson CEO Alex Gorsky joined other CEOs for dinner with President Donald Trump and it came with a prelude where Trump told reporters the administration has a plan to bring drug prices down “really substantially.”
-
Will more pharmas oppose Trump after Merck CEO's resignation?
fiercepharma
August 16, 2017
Merck CEO Ken Frazier stepped down from President Donald Trump's manufacturing panel and getting a response from the president.